Pregabalin NDC 43547-510

NDC codes

FDA NDC Directory

Product NDC (as listed)43547-510Labeler and product segments. Claims need a package NDC.

Product NDC at billing width43547-0510Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
43547-510-09	43547051009	90 CAPSULE in 1 BOTTLE (43547-510-09)Marketed from Jun 15, 2020
43547-510-11	43547051011	1000 CAPSULE in 1 BOTTLE (43547-510-11)Marketed from Jun 15, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pregabalin
Generic name (nonproprietary): pregabalin
Active ingredients: Pregabalin — 150 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Solco Healthcare US, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207883
Marketing start: Jun 15, 2020
Listing expires: Dec 31, 2027
DEA schedule: CV
Identifiers: Product ID 43547-510_a56adbdc-8347-4165-8b9f-f826ff51440cSPL ID a56adbdc-8347-4165-8b9f-f826ff51440cSPL set ID 085db834-3735-40d9-ac67-f9dbb82390c5RxCUI 483438, 483440, 483442, 483444, 483446, 483448, 483450, 577127UNII 55JG375S6MUPC 0343547507091, 0343547513092, 0343547506094, 0343547508098, 0343547509095

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N443547051009 followed by a unit qualifier and the quantity

Package 43547-0510-09. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 19, 2026.

Indications (excerpt from the label)

Pregabalin capsules are indicated for: • Management of neuropathic pain associated with diabetic peripheral neuropathy • Management of postherpetic neuralgia • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older • Management of fibromyalgia • Management of neuropathic pain associated with spinal cord injury Pregabalin capsules are indicated for: • Neuropathic pain associated with diabetic peripheral neuropathy (DPN) ( 1 ) • Postherpetic neuralgia (PHN) ( 1 ) • Adjunctive therapy for the treatment of partial-onset seizures in patients 1 month of age and older ( 1 ) • Fibromyalgia ( 1 ) • Neuropathic pain associated with spinal cord injury ( 1 )…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207883

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207883
Product	Strength	Form · route	Labeler	Product NDC
Pregabalin	Pregabalin 25 mg/1	CapsuleOral	Solco Healthcare US, LLC	43547-506
Pregabalin	Pregabalin 50 mg/1	CapsuleOral	Solco Healthcare US, LLC	43547-507
Pregabalin	Pregabalin 75 mg/1	CapsuleOral	Solco Healthcare US, LLC	43547-508
Pregabalin	Pregabalin 100 mg/1	CapsuleOral	Solco Healthcare US, LLC	43547-509
Pregabalin	Pregabalin 200 mg/1	CapsuleOral	Solco Healthcare US, LLC	43547-511
Pregabalin	Pregabalin 225 mg/1	CapsuleOral	Solco Healthcare US, LLC	43547-512
Pregabalin	Pregabalin 300 mg/1	CapsuleOral	Solco Healthcare US, LLC	43547-513